ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Formation Bio raises $600 million to fix AI's biotech bottleneck. The company, valued at $1.7 billion in 2024, uses AI to reduce clinical research costs by 30% to 50%. CEO Ben Liu states the fund will acquire molecules for development without diluting shareholders.
Tap to vote and see what everyone thinks.
Summary by ByteBrief